Michael Poyurovsky

Tel Aviv University — Israel

Psychology · Social Sciences

42h-index4.5kcitations136works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Obsessive-Compulsive Spectrum Disorders(71), Schizophrenia research and treatment(60), Autism Spectrum Disorder Research(34), Electroconvulsive Therapy Studies(26), Bipolar Disorder and Treatment(24)

Publications136 total

Quetiapine in the Treatment of Comorbid Burning Mouth Syndrome and Bipolar II Depression
Journal of Clinical Psychopharmacology·2024· 1 cited
Beneficial Effect of Quetiapine on Sleep, Anxiety, Depression and Myalgia Symptoms in a Patient With Post–COVID-19 Condition
Journal of Clinical Psychopharmacology·2023· 2 cited
Low-Dose Quetiapine Fumarate (50 mg) for Obsessive-Compulsive Disorder Patients With Comorbid Bipolar Depression
Clinical Neuropharmacology·2021· 2 cited
On the Estimation and Comparison of Lifetime Morbid Risks
Journal of Data Science·2021· 7 citedOpen Access
Rate of OCD and sub-threshold OCD in bipolar disorder patients with first depressive episode
Psychiatry Research·2021· 3 cited
Integration of mental health comorbidity in medical specialty programs in 20 countries
The International Journal of Psychiatry in Medicine·2021· 10 citedOpen Access
Quetiapine for Bipolar Depressive Episode in Obsessive-Compulsive Disorder Patients Maintained on Selective Serotonin Reuptake Inhibitor Treatment
Clinical Neuropharmacology·2021· 3 cited
Elevated rate of OCD-spectrum and tic disorders in patients with bipolar depression and comorbid OCD
Journal of Obsessive-Compulsive and Related Disorders·2021· 2 cited
Contributors
Elsevier eBooks·2021
Obsessive-Compulsive Schizophrenia and Obsessive-Compulsive Disorder
Elsevier eBooks·2021
Beneficial Effect of a Relatively Low Dose of Clozapine in a Bipolar Depression Patient With Comorbid Obsessive-Compulsive Disorder and Severe Suicidality
Clinical Neuropharmacology·2020· 4 cited
Beneficial effect of quetiapine monotherapy in patients with bipolar depression and comorbid obsessive-compulsive disorder
International Clinical Psychopharmacology·2020· 13 cited
Treatment of Antipsychotic-Induced Akathisia: Role of Serotonin 5-HT2a Receptor Antagonists
Drugs·2020· 44 cited
Beneficial Effect of Betahistine, a Structural Analog of Histamine, in Clozapine-Related Sedation
Clinical Neuropharmacology·2019· 8 cited
Integration of Mental Health Comorbidity in Medical Specialty Programs in 20 Countries
SSRN Electronic Journal·2019Open Access
Obsessive-Compulsive Schizophrenia: Clinical andConceptual Perspective
Psychiatric Annals·2018
Very Low-Dose Mirtazapine (7.5 mg) in Treatment of Acute Antipsychotic-Associated Akathisia
Journal of Clinical Psychopharmacology·2018· 10 cited
Efficacy and safety of antidepressant augmentation of continued antipsychotic treatment in patients with schizophrenia
Acta Psychiatrica Scandinavica·2018· 76 cited
Obsessive-Compulsive Symptoms in Schizophrenia
Oxford University Press eBooks·2017· 1 cited
Schizophrenia dissection by five anxiety and depressive subtype comorbidities: Clinical implications and evolutionary perspective
Psychiatry Research·2017· 19 cited
page 1 of 7Next →

Frequent Co-authors

Abraham Weizman(27), Ronit Weizman(20), Camil Fuchs(19), Sarit Faragian(13), Michael Schneidman(10), Artashes Pashinian(6), Martín Keller(5), Maya Bleich‐Cohen(5), Talma Hendler(5), Haggai Hermesh(4), Rachel Maayan(4), Artashez Pashinian(4), Amos Frisch(3), Elena Michaelovsky(3), Ilan Modai(3), R. Weizman(3), Irit Gil‐Ad(3), Aya Levi(3), Victoria Kriss(3), Gregory Weisman(3)